Showing posts with label deschedule. Show all posts
Showing posts with label deschedule. Show all posts

Monday, July 1, 2024

Rescheduling is a half-measure; the DEA must deschedule marijuana


The DEA must deschedule marijuana 

Dear Sir, 

The Biden Administration’s recent move to reconsider marijuana’s status as a Schedule I controlled substance under the Controlled Substances Act (CSA) is a step in the right direction, but it falls woefully short of what is needed. Rescheduling marijuana to Schedule III is not enough. Instead, it is time to end the failed policy of criminalization and completely remove marijuana from the CSA’s drug schedules. 

Given the Biden Administration’s acknowledgment of the racially discriminatory enforcement of marijuana laws, any policy development that ignores these considerations is unjustifiable. President Biden has repeatedly promised to decriminalize marijuana. The DEA should not undermine this commitment by finalizing the proposed rule to reschedule marijuana under the CSA. It is imperative for the Biden Administration to fulfill this promise by taking decisive action to end and repair the harms of federal marijuana criminalization. 

The only way to truly end federal marijuana criminalization and its associated harms is to completely deschedule marijuana from the CSA. A new federal marijuana policy should prioritize public health and equity. It should aim to end unjust criminal consequences, restore rights and opportunities for those affected by marijuana criminalization, and ensure a diverse marketplace that protects small businesses and equity programs from large corporate monopolies. 

The current proposal to reschedule marijuana fails to address the core issues of federal marijuana criminalization. Rescheduling will not stop federal arrests for possession and use, nor will it free those imprisoned for marijuana-related offenses. It will not expunge previous marijuana arrests, end deportations, or remove immigration consequences stemming from marijuana activity. Moreover, it will not restore access to government benefits lost due to marijuana-related activities or bring state marijuana programs into compliance with federal law. 
 
Even for the marijuana industry, rescheduling to Schedule III is inadequate. While it would eliminate certain federal tax penalties for state-regulated marijuana businesses, it would not provide them with legal access to essential business services, nor is it likely to result in significant wage increases for workers or lower prices for patients and consumers. More importantly, rescheduling would continue the criminalization of personal possession, cultivation, use, and participation in state-legal marijuana businesses. 

The process of evaluating marijuana’s status under the CSA is also deeply flawed. The administrative review conducted by the FDA and DEA is limited in scope and fails to consider the racist origins and impacts of marijuana prohibition. These policies have had devastating social, economic, and public health consequences, particularly for Black and Latino communities, which continue to suffer from mass incarceration, inaccessible public housing, and denial of food assistance programs. 

Furthermore, the U.S. has played a significant role in enforcing marijuana prohibition globally, with devastating consequences. With changing domestic realities, the U.S. has a responsibility to repair the damage caused by prohibitionist policies and support systemic changes internationally. Active diplomacy at the United Nations and other international forums is essential to challenge the outdated global drug control regime.  

Rescheduling marijuana is a half-measure that fails to address the root problems. To achieve meaningful reform, the DEA must issue a new rule to deschedule marijuana from the CSA entirely. 

As often heard in circles of those recovered from needless suffering, “Half measures avail us nothing.” 

Thank you. 

 
Michael Brennan 
Member, Board of Directors 
Coalition for Medical Marijuana—New Jersey, Inc. 
219 Woodside Ave Trenton, NJ 08618 United States

Wednesday, January 6, 2021

CMMNJ Year End Report 2020



The Coalition for Medical Marijuana New Jersey, Inc. (CMMNJ) is a non-profit educational organization incorporated in the State of New Jersey and recognized by the federal government as a 501(c)(3) public charity. The mission of CMMNJ is to educate the public about medical marijuana.  The goal of CMMNJ is to have safe and legal access to medical marijuana for New Jersey patients. March 10, 2020 was the 17th anniversary of the founding of CMMNJ.

CMMNJ’s public meetings for 2021 will continue to be held on the second Tuesday of each month from 7 - 9 pm via Zoom until further notice. All are welcome at these meetings and there is never a charge to attend. 

New Jersey Highlights of 2020

Voters agreed to legalize cannabis in New Jersey. The Final Election Results from November 3, 2020 on Question 1, a constitutional amendment to legalize cannabis for personal, non-medical use by adults who are age 21 years or older, subject to regulation by Cannabis Regulatory Commission, effective 1/1/21:

YES - 2,737,682 (67.08%)

NO - 1,343,610 (32.92%)

(As of 12/8/20 with 6,348 of 6,348 Precincts Reporting - 100%)

Home Cultivation: Visit the website: Let Patients Grow NJ #JeffsLaw.  Sign the petition for Home cultivation for patients: Let Patients Grow NJ.

The Medical Marijuana Program continues to expand with the Murphy administration, but additional ATCs are held up by legal challenges, and the 2019 Jake Honig law has yet to be fully implemented.

Marijuana reform made progress nationally and regionally.

CMMNJ supports Patients Out of Time’s coalition to deschedule cannabis.

Cannabis legalization

In 2014, CMMNJ’s Board of Directors endorsed legalization of marijuana since legalization is the best way to get this essential medicine to the most people. Legalization is also an important step in undoing the harms to society that are caused by our current policy of drug prohibition.

The New Jersey Legislature was unable to pass a marijuana legalization bill in 2019. Instead, cannabis legalization in NJ would be decided by a ballot question on November 3, 2020. The Constitutional Amendment that appeared on the ballot, SCR183/ACR840, passed in the Senate (24-16) and in the Assembly (49-24-1) on 12/16/2019, after Senate and Assembly hearings on 12/12/19. 

By March 2020, CMMNJ started a “Get Out the Vote” (GOTV) campaign. CMMNJ joined with HeadCount’s Cannabis Voter Project  and urged residents to text CANNA to 40649 or text WEVOTE to 40649. We urged residents to plant the seeds of change and #growyourpower; and to talk to elected officials about cannabis reform.

In April, CMMNJ began sending letters to all NJ colleges and universities in the state as part of our Get Out the Vote campaign.  We asked higher education administrators for their support in our efforts. It was a challenging time because no one knew for sure if there would even be students on campus in the fall. Nevertheless, we got some encouraging replies from various academic administration members. CMMNJ volunteer Dee Carnegia forwarded CMMNJ’s letter, GOTV at Princeton U, to about 50 NJ colleges and universities and she kept track of our efforts and followed up with emails and telephone contacts where appropriate. Another CMMNJ volunteer, Tracey McHugh, reached out to fraternities and sororities in the state with the same GOTV message.

An April poll showed 61% of NJ voters say they will approve the Constitutional amendment to legalize cannabis for adults. CMMNJ redoubled its efforts, believing that we should proceed as if we are behind in the polls and need to improve our standing. A later poll showed 68 percent of NJ respondents support legalizing cannabis for adults.

Cannabis Decriminalization bill A1897 passed in the NJ Assembly 6/18/20.

Due to the pandemic, Gov. Phil Murphy ordered millions of ballots to be mailed to voters by Oct. 5.  The state provided more ballot drop boxes. To count, ballots had to be postmarked by Nov. 3 and arrive no later than 8 PM a week after Election Day.

NJ.Com: Campaign to legalize marijuana kicks off with 55 days until election

In June, “NJ CAN 2020” joined the effort to approve the ballot question. NJ CAN 2020 had an experienced campaign manager, Axel Owen, who worked with CMMNJ closely. NJ CAN 2020 members included the ACLU NJ, the NAACP NJ, Doctors for Cannabis Regulation, NJ United for Marijuana Reform, the Latino Action Network, the American Trade Association for Cannabis and Hemp, Law Enforcement Action Partnership, & the NJ CannaBusiness Association. See NJ CAN 2020 30-second ad: Vote YES to Legalize Cannabis in New Jersey! 

Join Gov. Phil Murphy in the fight to legalize adult-use marijuana. Rick Steves helped with: It’s Time to Legalize Marijuana in New Jersey. Robert Platshorn supported the legalization effort with his video The Silver Tour.

CMMNJ held a Poster Contest to inspire people to vote YES on November 3rd. CMMNJ’s Poster Contest winner is the logo by Jo Anne Zito. Yard signs that were made with variations on this design were available from CMMNJ by October 9, 2020. Many volunteers helped to pay for and distribute the yard signs. 


Marijuana legalization won in all 21 counties in New Jersey, with approval rates from 75% in Camden County to 60% in Ocean County.  The Constitutional Amendment takes effect on 1/1/21. Per the ballot question’s Interpretive Statement: “The Cannabis Regulatory Commission (will) oversee the new adult cannabis market…The scope of the commission’s new authority (will) be detailed in laws enacted by the Legislature.” More info at: SCR183/ACR840.

Many thanks to the friends, family, colleagues, advocates, organizations, patients, and voters who made the victory for cannabis legalization possible. It was not just an election victory; it was a thorough repudiation of the war on marijuana in every county in New Jersey! CMMNJ said that our state is now on track to become healthier, wealthier, and safer!

On November 6th, Gov. Murphy Announced Cannabis Regulatory Commission Appointments: Dianna Houenou, Chair, & Jeff Brown, Executive Director. 

CMMNJ’s Adult-use Cannabis Recommendations were distributed:

However, as 2020 ended, N.J.’s legal cannabis bill was held up again at the final stage because Gov. Murphy wanted to clarify penalties for underage use.

HOME GROW

In January 2020, Jo Anne Zito published the Op Ed: Allow home cultivation of medical marijuana. See Facebook: #THEYSHALLGROW

Jo Anne and Jim Miller worked diligently for a home cultivation program for NJ MMP patients. They encouraged people to sign the petition: Let Patients Grow NJ. By March, about 800 had signed. The petition urged legislators to meet with CMMNJ to discuss patient concerns. Governor Murphy said he’d sign a Home Grow bill (Jeff’s Law) if we got it to his desk, but the bill still needs to be written and introduced. 

Also, CMMNJ encouraged visits to the website: Let Patients Grow NJ #JeffsLaw. We asked supporters to establish contact with NJ legislators and create an email trail and post it. In October, Jo Anne published another Op Ed: A few cannabis plants to love at home | Zito

New Jersey Department of Health Medicinal Marijuana Program (MMP)

The eighth anniversary of legal sales of marijuana in New Jersey was on 12-6-20. The tenth anniversary of New Jersey’s Compassionate Use Medical Marijuana Act becoming law was on 1-18-20.

In 2020, Alternative Treatment Centers (ATCs) serving medical marijuana were designated “essential services” by the State of New Jersey and allowed to continue operating during the pandemic. The Department of Health (DOH) allowed ATCs to offer curbside pickup to patients. Caregiver fees are reduced to $20. However, patients still saw long lines at ATCs, reduced availability of specific strains, and temporary ATC closings.  In May, Jeff Brown said, “More can be done.” 

There are thirteen ATCs currently dispensing medical marijuana at the end of 2020 (9 ATCs & 3 satellites) to serve over 80,000 patients.

Columbia Care in Vineland, 

Ascend Wellness, (formerly Greenleaf) in Montclair, 

The Botanist (Compassionate Care Foundation) Egg Harbor & Atlantic City, 

Garden State Dispensary in Woodbridge, Eatontown, and Union Township,

Breakwater in Cranbury, 

Curaleaf in Bellmawr, 

Harmony in Secaucus, 

Rise in Paterson, 

Zen Leaf in Elizabeth,

Apothecarium in Phillipsburg, NJ opened in November 2020.

In August 2020, New Jersey state officials allowed providers to remotely prescribe medical marijuana during the coronavirus pandemic using telemedicine.

The  DOH changed and reissued the RFA for 24 new ATCs in NJ on 7/1/19, including up to 8 in the north, 8 in central NJ, 7 in the south, and 1 “at-large”; these include 5 for cultivation, 15 dispensaries, and 4 vertically integrated permits. Application forms were posted July 15; due on 8/21 (Dispensary) and 8/22 (Cultivation & Vertically Integrated). An NJ appellate court agreed to halt the review of 196 applications for 24 medical marijuana licenses. The DOH said 51 applications were disqualified for various reasons, but applicants are appealing that decision. The Appellate court on 7/2/20 denied the DOH motion to end the stay and award ATC licenses. The DOH defended its actions, saying it was for good reasons that certain applicants were rejected on November 18, 2019. (Awards were supposed to be announced in December.) This continues to halt the progress, over a year later, of 24 additional NJ medical marijuana licenses. State urged to compromise. Linda Graves, an applicant, gave updates on the issue at monthly CMMNJ meetings. Many applicants are being harmed financially by the delay. There may be additional legal challenges and appeals. 

A three-judge appellate court vacated the 2018 decision to award six licenses for new medical marijuana companies and remanded it to the health department to develop a new rating system. The court did not revoke the six licenses though.

Ed Tobias, Esq. prepared a brief due March 30th—he wants more licenses. Ed also has the first license to grow hemp in NJ—he said anyone can get one for $400. 

The NJ tax on medical marijuana dropped on July 1 from 6.625% to 4%. Next year at this time it will be 2% and the following year 0.

An NJ appellate court ruled in favor of reimbursement for a worker’s medical marijuana after a workplace accident. On March 10, 2020, the NJ Supreme Court affirmed the appellate decision in the Wild case and ruled employers cannot fire workers who use medical marijuana while off the job.

A Medical Cannabis Dispensary Technician training class will be held this spring at the Raritan Valley Community College in Branchburg, NJ.

NJ patients were advocating for home delivery along with home cultivation. CMMNJ encouraged supporters to send the letter from NORML to Allow Home Delivery for medical marijuana patients! The NJ MMP issued regulations on 6/25/20 to allow ATCs to begin home delivery. However, by the end of 2020, ATCs had still not implemented this service.

There was a weekly record increase of patients in the MMP during the week of 3/20/20 when over 4,000 patients joined the program. Ken said in a media interview that he thought this was likely due to an increase in community anxiety brought about by the coronavirus pandemic.

Marijuana rescheduling/descheduling and national issues

The New Jersey Superior Court Appellate Division heard oral arguments for marijuana rescheduling/descheduling in New Jersey on 11/29/16 in Trenton. Nearly a year later, in November 2017, the Appellate Court ruled that the Director of the Division of Consumer Affairs (“the Division”) in the New Jersey Attorney General’s office erred when he said he lacked the authority to reclassify/reschedule/de-schedule marijuana. The Director must reconsider his decision in the “post-CUMMA era” the court said. New Jersey must recognize marijuana's medicinal value, the court insisted. The Division recognizes that it has the authority to reevaluate how marijuana is classified under state law.

Accordingly, rescheduling/descheduling hearings were held by the New Jersey Office of the Attorney General on 4/19/18 in Newark and on 4/24/18 in Trenton. For CMMNJ testimony, click the links. We still await summaries or other results of these hearings. 

Patients Out of Time has created a coalition of organizations and individuals to demand the end of federal cannabis prohibition with their Resolution to De-Schedule Cannabis. Please share. 

Ken commented on a Proposed Rule by the Drug Enforcement Administration, DEA’s announcement that it will begin processing applications to cultivate marijuana for research. 

On Election Day, November 3rd, 2020, the following states legalized marijuana for adults: Arizona, Montana, and South Dakota, along with New Jersey. South Dakota also legalized medical marijuana, as did Mississippi. Oregon decriminalized all drugs.  In Illinois, legal marijuana sales began 1/1/20.

On December 4, 2020, the U.S. House of Representatives passed H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement Act of 2020 (MORE Act.)  This bill would decriminalize and deschedule cannabis, provide for reinvestment in persons adversely impacted by the War on Drugs, and provide for expungement of federal cannabis offenses. There are concerns about this bill.

2020 CMMNJ Publications

CMMNJ Monthly Agendas and Minutes also contain links to published reports by and about CMMNJ Board members and friends.  For the CMMNJ Agendas and Minutes, see the CMMNJ blog. May 16, 2020 was the 11th anniversary of the CMMNJ blog.

CMMNJ Meeting Agenda for December 8, 2020

CMMNJ November 10, 2020 Meeting Agenda 

CMMNJ’s Adult-use Cannabis Recommendations

CMMNJ Meeting Agenda for October 13, 2020 and September Minutes

CMMNJ Public Meeting Agenda for September 8, 2020 and August Minutes

CMMNJ Public Meeting Agenda for August 11, 2020 and July Minutes

CMMNJ Public Meeting Agenda for July 14, 2020 and June Minutes

CMMNJ Public Meeting Agenda for June 9, 2020 and May Minutes

CMMNJ Public Meeting Agenda for May 12, 2020 and April Minutes

CMMNJ Public Meeting Agenda for April 9, 2020 and March Minutes

CMMNJ Public Meeting Agenda for March 10, 2020 and February 4, 2020 Minutes.

CMMNJ Public Meeting Agenda for January 14, 2020 and December 2019 Minutes:

CMMNJ Year End Report 2019

In May, Ken resurrected his first public call for marijuana reform--a Letter To The Editor of The Evening Times of Trenton, NJ published on August 10, 1972: 

CMMNJ’s Board member Peter Rosenfeld published an Op Ed supporting the adult use ballot question in NJ.

Board member Jo Anne Zito published an Op Ed 8/25/20: I’ve been unjustly criminalized by N.J.’s cannabis laws. Decriminalize it now! 

CMMNJ members took part in events and stories in 2020

American Cannabis Nurses Association: 2020 Annual Conference...A Virtual Experience, 12/6-8/20.

“Green Repeal” (46-minute podcast): “How the Coronavirus is Affecting the Cannabis Industry with Ken Wolski." 

NJ Cannabis Insider: Q&A with Ken Wolski.

WEED THE PEOPLE New Jersey CANNABIS Symposium Why vote YES on Ballot Initiative on November 3rd  #RUTGERS

Profile of CMMNJ Executive Director: Cannabis influencers: The tireless nurse and original advocate for medical marijuana

Letter To the Editor: Irony from N.J. pot-bill obstructionist

The CannAtlantic Cannabis Conference, 9/26/20

For marijuana advocate Ken Wolski, legalization of drug was long overdue: Phil Gianficaro, Burlington County Times, 11/8/20.

Drug War Chronicle: Will New Jersey Be the Next State to Legalize Weed?

Delaware cannabis legalization panel, December 16, 7pm-9pm via Zoom. 

“Cannabis: A Handbook for Nurses” by Carey S. Clark 

“Seniors and Medical Marijuana,” JCC, Edison, NJ, 2/11/20.

“Seniors and Medical Marijuana,” Princeton Present Day Club, 3/4/20.

Princeton Senior Resource Center: “MEDICAL MARIJUANA” Friday, Oct 23

March Against the War on Drugs, 7/10/20, Newark City Hall to Peter Francisco Park Rally 

Sativa Cross Podcast, 4/20/20,  Trenton State House, 7/2/20, 7/23, 8/27, 9/24, 10/22, 11/26, 11am to 2 pm. 

Decriminalization Rally for bill S2535 State House, Trenton, 8/27/20.

ASA Unity Conference, Washington, D.C., March 25 – 28, 2020, online only.

The Shore Grow fundraiser for Patient Aid on 9/26/20

NJ Cannabis Legalization Overview Webinar Hosted by Black Cannabis

Interviews with Dean Becker of Drug Truth Network: 1/2/20 & 1/3/20. 

Open Forum on Legalization of Cannabis, Atlantic City, 3/4/20.

NJCBA Webinar 4/15/20, 12 – 1 pm.

Canna Pop Up, 4/20/20, noon to 5 pm.

CannaGather Digital History & Science of Culinary & Cannabis, 5/7/20.

Cannabis and COVID-19: Where Does America Go From Here? Webinar, May 13.

ArcView Town Hall: All things New Jersey Cannabis Landscape, 16 Dec 2020 

Military Matters podcast: Episode 1: Cannabis – what are the facts, and can it be helpful?

Steven Kadonsky was released from New Jersey State Prison after 26 years of incarceration for a nonviolent marijuana offense—his first offense! See his story here: The Steven Kadonsky Story

CMMNJ testified at the NJ Senate Judiciary Committee Hearing, 11/9/20 on S21 Cannabis Regulatory, Enforcement Assistance, & Marketplace Modernization Act; legalizes personal use cannabis for certain adults, subject to regulation by Cannabis Regulatory Commission; removes marijuana as Schedule I drug.  

Assembly Oversight, Reform and Federal Relations Committee Hearing, 11/09/20; and the Assembly Appropriations Committee, 11/12/20 on S2535 Marijuana-provides criminal and civil justice reforms; A1897 Marijuana-decriminalizes 10 grams; 

With CMMNJ’s encouragement, advocates attended and spoke up at local council meetings and other civic meetings throughout the state in support of marijuana reform. Jim Miller went to the Toms River council and Lefty Grimes and the Ignorance is No Excuse tour went to many communities.

#JusticeforJawara: Jawara McIntosh died 7/17/20 from injuries he sustained while in Bergen County Jail on a marijuana offense. The 2017 attack left Jawara with severe brain injuries that led to his death. Jawara was in jail because he was caught with marijuana, a sacrament in his Rastafarian Religion. 

Thanksgiving Giveaway: Sativa Cross, CMMNJ, & UFCW distributed donated food, clothing and personal hygiene items to the homeless and poor of Trenton at the Trenton State House Annex on 11/26/20. 

The 17th anniversary of CMMNJ’s first public event at the White Dog Café was on 3/10/20. Cheryl Miller, the multiple sclerosis patient, early NJ medicinal marijuana activist, and wife of CMMNJ co-founder Jim Miller, died on June 7, 2003.

Thanks to CMMNJ Volunteers

On behalf of the Board of Directors of CMMNJ, I would like to thank all our supporters for their tireless efforts and contributions throughout the year.  As we are an all-volunteer organization, we are nothing without you!  Special thanks go to:

⦁ volunteer administrators who moderate the many discussions on Facebook’s Friends of the Coalition for Medical Marijuana-NJ;

⦁ activists who spoke out at community meetings to dispel marijuana stigmas;

⦁ activists who contacted the media and elected officials for marijuana reform;

⦁ special “Thank you” to all who contributed food, clothing, and cash to the CMMNJ & Sativa Cross Thanksgiving Food & Clothing Giveaway at the Trenton State House.

CMMNJ 2020 Board Update

Frequent Board discussions were conducted by group emails and messages as opposed to formal Board meetings during 2020. At the close of the year, the CMMNJ Board consists of the following 11 people: 

Kenneth R. Wolski, RN, Executive Director; 

James Miller; Jim Miller, Longtime Advocate, and NJ Homegrow Leader

Edward R. Hannaman, Esq., Secretary; 

Nick Mellis; 

Peter Rosenfeld; 

Larry Vargo;

Amanda Hoffman;

Jo Anne Zito; 

Philippe Dume; 

Gaetano Lardieri: Cannabis Science Leader and Advocate;

Michael Brennan; Leading Cannabis Activist, Advocate & Patient 


CMMNJ’s Honorary Board Member is Allan Marain, Esq.

Treasury Report

Treasury report: In 2020 CMMNJ had expenditures of $3,707 and income of $5,664 for a gain this year of $1,924. CMMNJ finished the year with a checking account balance of $4,938 and a PayPal account balance of $3,224 for a grand total of $8,162.

The Shore Grow fundraiser for Patient Aid on 9/26/20 raised $2275 for CMMNJ! Many thanks to Tom@ShoreGrow.com, Doug, Eva and the Shore Grow team for the most successful fund raiser in CMMNJ’s 17-year history! 

CMMNJ still has almost 50,000 all hemp wristbands and necklaces that were donated to our organization. The multicolored bands were made in Romania. The suggested price is $1 apiece.  Wholesale prices are available.

CMMNJ is grateful for the generous financial support of all who contributed to our mission. This includes those who contributed anonymously through Network for Good. Many people also generously donated their time, their professional and personal services, office space, supplies, etc. to CMMNJ.

Many thanks to the Byrne family of Ewing, NJ, who, on the untimely death of their son, Will, directed memorial contributions to CMMNJ. The Byrnes said that medical marijuana greatly improved the last year of their son’s life. Even in their grief, they reached out to help others.

CMMNJ’s 2021 Recommendations

⦁ Allow registered patients in the NJ MMP to grow a limited supply of cannabis (Home Grow Now!)

⦁ Implement a timely legalization program that brings affordable, high quality marijuana to New Jersey adults in an appropriately regulated, socially just way. See CMMNJ’s complete Adult-use Cannabis Recommendations.

⦁ CMMNJ renews its annual call for national clinical trials of marijuana.

⦁ Deschedule marijuana, both in New Jersey and nationally.

Schedule of CMMNJ 2021 meetings

Plans for 2021 are to continue with monthly Zoom meetings until further notice.

In 2020, CMMNJ held twelve free public meetings on the second Tuesday of each month from 7 - 9 PM. The meetings from January through March 2020 were held at the Lawrence Township Library in Mercer County.  (Meeting at the library does not imply the county’s endorsement of our issue.) Due to COVID-19 restrictions, the meetings from April through December were conducted via Zoom conferences.  In the past the CMMNJ Board objected to having a permanent record of meeting discussions. This was out of concerns about patient confidentiality, and patient self-incrimination when discussing use of an illegal substance. As usual, in the beginning of the Zoom meeting, participants introduced themselves and said a few words about why they were at the meeting. We advised participants that there was no way to tell if their comments were being recorded.

CMMNJ sent the agendas for these meetings via e-mail to over 1000 supporters each month and posted the agendas on Facebook, Twitter and on the CMMNJ blog. 

To receive the meeting agendas, sign up!  

We extend our best wishes for everyone’s safety and health during this time of pandemic, social distancing, and economic collapse. 

Follow CMMNJ

Coalition for Medical Marijuana - New Jersey: web site: http://www.cmmnj.org

Facebook: Friends of the Coalition for Medical Marijuana-NJ  

or, Coalition for Medical Marijuana - New Jersey

Twitter: @CMM_NJ

CMMNJ blog: https://cmmnj.blogspot.com/

More Info:

Ken Wolski, RN, MPA, Executive Director

Coalition for Medical Marijuana—New Jersey, Inc. 

219 Woodside Ave., Trenton, NJ 08618  

(609) 394-2137 

ohamkrw@aol.com; kenwolski@gmail.com


January 6, 2021


Tuesday, February 5, 2019

February 12, 2019 CMMNJ Public Meeting Agenda



Monthly Public Meeting Agenda 
Lawrence Township Library, Room #3 
Tuesday, February 12, 2019 7:00 PM -- 9:00 PM
Weather Closing: 
CMMNJ Meeting Canceled for tonight, February 12, 2019: 
All Mercer County Library branches are closed today.
https://mcl.org/branches/lawrbr.html

Approve January 2019 minutes. Discuss:

NJ marijuana reform delayed. S2703/A4497: The “New Jersey Cannabis Regulatory and Expungement Aid Modernization Act” which legalizes personal use of cannabis for adults passed legislative committees 11/26/18 but there has been no action, or a floor vote, since.

There is, however, progress in PA & NY to legalize marijuana in 2019.

The Compassionate Access, Research Expansion and Respect States (CARERS) Act was re-introduced in the 116th Congress. New congressmen/women plan to hold House hearings on marijuana.

The medical marijuana expansion act, S10/2426, is also stalled, after sailing through three NJ legislative committees, also on 11/26/18. This bill is unfairly tied to the legalization bill.

NJ DOH OK’d 6 applications for ATCs on 12/17/18 for Atlantic City, Elizabeth, Ewing, Paterson, Phillipsburg & Vineland. Lawsuits challenge the awards. MMP now has over 40,000 patients.

OUD OK’d for marijuana therapy. Dr. Elnahal continues outreach to NJ MDs.

CBS refuses to air medical marijuana ad during Super Bowl.

NJ DOH MMP proposed regulations: CMMNJ awaits adoption of rules: our comments.

NJ OAG: CMMNJ awaits action on re/descheduling hearings from  the spring of 2018.

Upcoming Events: Patients Out of Time (POT) conference, Tampa, FL, 4/11-4/13/19.
Americans for Safe Access (ASA) Unity Conference, Washington, D.C., 3/18- 3/20/19.
Medical Marijuana in New Jersey, Hackensack UMC, Pascack Valley 2/16/19, 8am – noon.
5th Annual CANNAEAST Conference March 12-13, 2019 New York, NY.
Medical Marijuana & Industrial Hemp, Cooper U. Med School, 3/22/19, 8 am – 11 am.
Community Cannabis Forum, Mt. Zion Baptist Church, Pleasantville, NJ, 4/4/19, 7 – 9 pm.

Recent events: Brick Zoning Board hearing cancelled on January 9, 2019; rescheduled for 2/27.
“Medical Marijuana in New Jersey”, 2/2/19, Penn Medicine/UMCP, Plainsboro, NJ.

Treasury report: Checking: $4907; PayPal: $2668. NJ Annual Report filed ($27.50).

CMMNJ’s free, public meetings are the 2nd Tuesday of each month from 7 – 9 PM at the Lawrence Twp. Library, 2751 Brunswick Pike, Lawrence Twp., 08648. All are welcome. (Meeting at the library does not imply Mercer County’s endorsement of our issue.)
More info: Ken Wolski, RN, MPA (609) 394-2137 ohamkrw@aol.com http://www.cmmnj.org
Facebook: Friends of CMMNJ & Coalition for Medical Marijuana--New Jersey.
CMMNJ blog: Agendas from 2009 to present.
Twitter:  Coalition for Medical Marijuana--NJ  @CMM_NJ

CMMNJ, a 501(c)(3) public charity, is a non-profit educational organization.




Monthly Public Meeting Minutes 
January 8, 2019

December 2018 minutes approved.

NJ marijuana reform delayed. S2703/A4497: The “New Jersey Cannabis Regulatory and Expungement Aid Modernization Act” which legalizes personal use cannabis for adults did not go to a vote by the entire legislature on December 17th, as hoped, after successfully passing appropriations committees from the Senate and Assembly on November 26th. It appears too many people want too many things from the legislation, and are unwilling to compromise. Discussion about taxes for cannabis—who wants what? People who want expungement now must wait 6 years, but it may be reduced to one year—S.F. has a good program. While there appears to be little support in legislature for home cultivation (and with the governor) advocates will never give up on it. Asm. Conaway’s COS met with Mike to discuss issue. Ed to see DPA’s position on home cultivation. One suggestion—tax the clones from dispensaries?

Eliminate the sales tax on medical marijuana—Jim M. to start a petition to end this sales tax immediately. Court challenge to get money back from illegal sales tax on medicine?
PA & NY to legalize in 2019? Will this encourage home cultivation?

The medical marijuana expansion act, S10/2426, is similarly stalled, after sailing through three legislative committees, also on November 26th. This bill is tied to the legalization bill, though there is really no reason that it could not advance on its own.

Hemp Bill cannot go forward with federal govt. agencies like USDA shut down. Licenses and programs still need OK to go forward and need approval for CBD as a food product.

NJ DOH OK’d 6 applications for ATCs on 12/17/18 in Atlantic City, Elizabeth, Ewing, Paterson, Phillipsburg & Vineland. Applicants must comply with background checks and regs.

NJ DOH MMP proposed regulations: CMMNJ awaits adoption of rules: our comments.

NJ OAG: CMMNJ awaits action on re/descheduling hearings from  the spring of 2018.

Upcoming Events: Patients Out of Time (POT) conference, Tampa, FL, 4/11-4/13/19.
Americans for Safe Access (ASA) Unity Conference, Washington, D.C., 3/18- 3/20/19.
Brick Zoning Board hearing resumes on January 9, 2019.
Medical Marijuana in New Jersey, (4 CEUs for RNs) 2/2/19, 8am – 12 pm, Penn Medicine Princeton Medical Center, Plainsboro, NJ.
Medical Marijuana in New Jersey (4 CEUs for RNs) presentation is also available at Hackensack UMC at Pascack Valley on 2/16/19, 8am – 12 pm.
5th Annual CANNAEAST Conference March 12-13, 2019 New York, NY.

Treasury report: Checking: $4924; PayPal: $2668.


More info: Ken Wolski, RN, MPA (609) 394-2137 ohamkrw@aol.com http://www.cmmnj.org
Facebook: Friends of CMMNJ: https://www.facebook.com/groups/62462971150/

CMMNJ, a 501(c)(3) public charity, is a non-profit educational organization.

Thursday, April 26, 2018

Deschedule Marijuana


Deschedule Marijuana: Remove it from the list of Controlled Dangerous Substances


Testimony to the 
Office of The Attorney General
Division of Consumer Affairs
The Richard J Hughes Justice Complex
Attorney General's Library 
Trenton NJ 08611

April 24, 2018

by:
Kenneth R. Wolski, RN, MPA
219 Woodside Ave., Trenton, NJ  08618
(609) 394-2137 kenwolski@gmail.com

Dr. Sanjay Gupta, who was President Obama's original choice to be U.S. Surgeon General, said, "We have been terribly and systematically misled (about marijuana) for nearly 70 years in the United States." This misinformation, fed by decades of cherry-picked science, continues. The National Institute on Drug Abuse (NIDA), which refuses to allow research into the benefits of medical marijuana, and only permits research into its harms, is an important part of this misinformation. The federal government still insists that there are no accepted medical benefits of marijuana despite the facts that: 
  • 30 states have passed laws recognizing marijuana as medicine; 
  • over a million Americans use marijuana with a physician's recommendation;
  • scores of healthcare organizations endorse medical marijuana; and, 
  • an entirely new field of science, based on the discovery of how marijuana actually works in the human body--the Endocannabinoid system--is emerging.

The issue is personal as well as professional for me.

In 1966, when I was a senior at Trenton Central High School, I did a term paper on drugs. Shortly after my research was completed I determined to try marijuana for myself. Marijuana was fairly easy to obtain, even back then. I experimented with marijuana a few times before I graduated from high school, over 50 years ago. I was convinced, even then, that the government was exaggerating the dangers associated with marijuana, as it continues to do today.

By 1969, I was a full time college student and I was using marijuana regularly, a couple of times a week. I was an advocate for marijuana law reform, and I was thrilled that the 1937 Marijuana Tax Act was declared unconstitutional by the U.S. Supreme Court on May 19, 1969. It was a political decision to ban marijuana in 1937, not a medical or scientific one. Previous scientific studies like the Indian Hemp Drugs Commission Report were ignored. The draconian penalties against the possession, use and cultivation of marijuana were entirely inappropriate. These penalties were the result of government misinformation and propaganda that insisted that the use of marijuana led invariably to “insanity, criminality and death.” My own direct experience, and the experience of millions of others, was that the use of marijuana was more likely to lead to “peace, love and happiness.”

For a short time in 1969 and 1970, there was no federal law against the use of marijuana. My initial elation at this fact was tempered by the realization that the vast majority of marijuana arrests were at the state and local level. The laws against marijuana at these levels were still intact and marijuana arrests were rising every year nationally. According to the National Organization for the Reform of Marijuana Laws (NORML), annual marijuana arrests in the U.S. went from 31,000 in 1966 to 188,000 in 1970:

My hopes for reform of marijuana laws were further tempered by Congress rushing through the Controlled Substances Act (CSA). The CSA was introduced in Congress in September 10, 1970 and signed into law by President Richard Nixon on October 27, 1970. I well remember the controversy and even outrage from some when it was learned that marijuana was to be included, along with heroin, as a Schedule I drug, meaning that it had no accepted medical uses in the U.S.

A growing population of health care professionals and patients realized by 1970 that marijuana had medical uses, at a minimum for use in the management of glaucoma and for the nausea and vomiting associated with chemotherapy. My research showed that marijuana was used medicinally in many different cultures throughout history. Indeed, marijuana was a recognized medicinal in the U.S. for about 100 years, from approximately 1840 to 1940. There were about 100 articles about the therapeutic value of cannabis/marijuana in the American scientific journals of the day. Marijuana/cannabis was removed from the U.S. Pharmacopeia in 1942 because of a campaign of government propaganda against it that led to the passage of the now-unconstitutional Marijuana Tax in 1937. Marijuana was taken OFF the U.S. market for political reasons when Congress passed the Marijuana Tax Act in 1937.  There was no scientific evidence that marijuana led to “insanity, criminality and death” as alleged by government officials then.  Marijuana was legal in the U.S. for medical purposes longer than it was illegal.

To quell the outrage about marijuana’s inclusion as a Schedule I drug, the government promised that this was only temporary, pending the results of a commission that was being appointed to study whether marijuana was appropriately included as a Schedule I drug. 

After the CSA passed in 1970, President Nixon appointed the Shafer Commission to study whether marijuana was properly classified.  The Shafer Commission, a handpicked group of conservative politicians and academicians, studied the issue for almost two years.  Their findings were that marijuana should not be included as a scheduled drug at all, but rather that it be decriminalized for adult use in the U.S.  The Shafer Commission said, “The actual and potential harm of use of the drug is not great enough to justify intrusion by the criminal law into private behavior.”  However, President Nixon ignored the results of the commission he appointed.  

I recommend that the entire Report of the National Commission on Marihuana and Drug Abuse, “Marihuana: A Signal of Misunderstanding” commissioned by President Richard M. Nixon, March, 1972 be entered into the record of this hearing.

Some salient excerpts from the above report include: 
  • “Cannabis sativa has been used therapeutically from the earliest records, nearly 5,000 years ago, to the present day (Mikuriya, 1969: 34) and its products have been widely noted for their effects, both physiological and psychological, throughout the world.”
  • “For a half-century, official social policy has been not only to discourage use but to eliminate it…With the principal responsibility for this policy assigned to law enforcement, its implementation reached its zenith in the late 1950's and early 1960's when marihuana-related offenses were punishable by long periods of incarceration. This policy grew out of a distorted and greatly exaggerated concept of the drug's ordinary effects upon the individual and the society.”
  • “Marihuana's relative potential for harm to the vast majority of individual users and its actual impact on society does not justify a social policy designed to seek out and firmly punish those who use it. This judgment is based on prevalent, use patterns, on behavior exhibited by the vast majority of users and on our interpretations of existing medical and scientific data. This position also is consistent with the estimate by law enforcement personnel that the elimination of use is unattainable.”
  • “The criminal law is too harsh a tool to apply to personal possession even in the effort to discourage use. It implies an overwhelming indictment of the behavior which we believe is not appropriate.”
  • “The most notable statement that can be made about the vast majority of marihuana users-experimenters and intermittent users-is that they are essentially indistinguishable from their non-marihuana using peers by any fundamental criterion other than their marihuana use.”
  • “On the basis of our findings…we have concluded that society should seek to discourage use, while concentrating its attention on the prevention and treatment of heavy and very heavy use. The Commission feels that the criminalization of possession of marihuana for personal is socially self-defeating as a means of achieving this objective.”
  • “Marijuana has important therapeutic qualities which should be aggressively explored.”
  • “The existing social and legal policy is out of proportion to the individual and social harm engendered by the use of the drug.”


In 1972 the Alliance for Cannabis Therapeutics (ACT), and National Organization for the Reform of Marijuana Laws (NORML) petitioned the Bureau of Narcotics and Dangerous Drugs (BNDD) to reschedule marijuana to a Schedule II drug, to make it available for doctors to prescribe. The BNDD, which was the precursor to the DEA, and later the DEA refused to hold hearings for 14 years. They had to be taken to court three times before they would hold the hearings and finally in 1986, hearings were begun. 

Regarding these hearings, I highly recommend the two volume book, “Marijuana, Medicine & the Law,” R.C. Randall, editor, Galen Press, Washington, D.C., 1988. Volume I is the record of “Direct Testimony of Witnesses On Marijuana’s Medical Use In The Treatment of Life- & Sense-Threatening Diseases Including Cancer, Glaucoma, Multiple Sclerosis, Para- & Quadriplegia, Chronic Pain & Skin Disorders In Hearings Before The U.S. Drug Enforcement Administration.” Volume II is the record of “Legal Briefs, Oral Arguments & Decision Of The Administrative Law Judge On Marijuana’s Medical Use In the Treatment of Life- & Sense-Threatening Diseases.”

Doctors, nurses, patients and researchers testified that marijuana should be available. Researchers additionally testified about the difficulty of conducting research on marijuana due to the federal government’s restrictions. The DEA testified why marijuana should remain unavailable. The decision was given by the US Department of Justice, DEA Administrative Law Judge Francis L. Young on September 6, 1988. He said:
  • “The evidence in this record clearly shows that marijuana has been accepted as capable of relieving the distress of great numbers of very ill people, and during so with safety under medical supervision.”
  • “It would be unreasoning, arbitrary and capricious for DEA to continue to stand between these sufferers and this substance in light of the evidence in this record.”
  • “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man.” 

Marijuana should have been rescheduled and approved nationwide for medical use then and there. Unfortunately, the Administrator of the DEA overturned the judge’s decision, acting in an arbitrary, capricious and unreasoning manner.

Subsequent attempts to reschedule marijuana on the federal level have been unfairly frustrated and similarly unsuccessful. The DEA even manipulates the English language. In its July 2011 denial of a nine-year-old petition to reschedule marijuana, the DEA said that marijuana had a high potential for abuse. But according to the DEA, abuse of marijuana does not mean that the use of marijuana is interfering with a person’s life in some negative way, marijuana abuse means any use of marijuana, even when recommended by physicians in state-legal programs, since marijuana is federally illegal except for research purposes. Like in Alice in Wonderland, words mean what the DEA wants them to mean.

The DEA also said in July 2011 that it could not reschedule marijuana because no large-scale clinical trials have been done. There have been a number of very successful small-scale double-blind, placebo controlled clinical trials of marijuana in the U.S. These successful trials would presumably lead to large-scale trials. But NIDA, the only official source of research grade marijuana in the U.S., following its mandate, does not approve research into the benefits of marijuana. Moreover, NIDA has never had a sufficient supply of marijuana to conduct these trials. 

Professor Lyle Craker from the University of Massachusetts/Amherst faculty is an example of an unsuccessful 10-year struggle to grow a sufficient supply of marijuana to conduct large scale clinical trials. Prof. Craker’s research was approved by the university and the FDA, but DEA refused to allow him to proceed. The professor took DEA to court and DEA’s own Judge Bittner ruled the professor should proceed, and that the federal government’s supply of marijuana was “inadequate” but DEA overruled the judge: http://www.maps.org/research/mmj/mmj-news/2525-background-on-the-craker-lawsuit


As we have seen, researchers have complained for over 30 years that access to marijuana for research purposes has consistently been stymied.  It is absurd to have DEA be the final arbiter of what clinical and scientific studies can be done on marijuana in America. DEA is part of the Department of Justice—federal police. We should not have federal police guarding and limiting our scientific borders. This is inappropriate and unreasonable. We must resolve, as a nation, to stop DEA’s interference with science and medicine and never let it happen again.

This is beyond Kafkaesque. It is an embarrassment to science, to countless health care professionals and to patients nationwide.

I have been hearing since the 1960’s that more research on marijuana is needed. In all that time, there has never once been a clinical trial of marijuana in New Jersey for any disease, symptom or medical condition. 

Opponents of marijuana reform say that there are no long term studies of the safety of marijuana, and that we must wait 20 years or so for these long-term studies to be completed—studies that have not even begun yet. This is nonsense. Millions of Baby Boomers have been using marijuana for 50 or more years. You have only to look around you for evidence of marijuana’s long term safety. It promotes nothing but useless suffering to say more study is needed and then do nothing about the lack of studies.  

For the following reasons, marijuana must be rescheduled in New Jersey:
  • Marijuana is considered medicine in 30 states, including New Jersey and the District of Columbia, by duly passed legislation; and, 
  • Marijuana has historically been used as a medicine both in the United States and in much of the world; and,
  • The Shafer Report concluded that marijuana was misclassified as a Schedule I drug and should be decriminalized for adult use in the U.S.; and,
  • DEA Judge Francis Young concluded that marijuana should be rescheduled after a public hearing on the issue; and,
  • Numerous legitimate health care organizations have issued statements that recognize the therapeutic safety and efficacy of marijuana.

In 2008, the American College of Physicians (ACP), the country’s second-largest physician group called on the federal government to reschedule marijuana. In 2009, the American Medical Association (AMA) urged the federal government to reschedule marijuana. The ACP and the AMA join the American Nurses Association, the American Academy of Family Physicians, the British Medical Association, the Canadian Medical Association, and dozens of other organizations of healthcare professionals in calling for rescheduling of marijuana, but the federal government continues to refuse to do so.

The U.S. Supreme Court has already acknowledged (in the Garden Grove decision) that states have the right to determine the proper practice of medicine within each state.  In the Garden Grove case the U.S. Supreme Court let stand a lower court’s decision that said: "Congress enacted the Controlled Substances Act to combat recreational drug abuse and curb drug trafficking.  Its goal was not to regulate the practice of medicine, a task that falls within the traditional powers of the states.”

Marijuana prohibition rests on a lie. The lie is that marijuana is a Schedule I drug, with no accepted medical uses in the U.S., is unsafe for use even under medical supervision, and it has a high potential for abuse. None of that is true. New Jersey is one of 30 states that have accepted medical uses for marijuana; the safety profile of marijuana is the envy of most prescription drugs and even many over-the-counter drugs, and while marijuana may have a high potential for use, it does not typically interfere with a person’s life to the extent that it could be considered “abuse.” Most people who use marijuana—about 20 million Americans a month—use it periodically or episodically. As a Schedule I drug, marijuana is in the same class with heroin, a powerfully addictive and potentially deadly drug. Yet marijuana is about as addictive as caffeine and has never killed anyone through overdose. To put marijuana in the same class with heroin is absurd. Even children know that. When minors find out they have been lied to about marijuana they will not believe the very real dangers that can be associated with the use of other drugs. This Big Lie is the basis for the current draconian penalties against marijuana and it is an appalling lie to tell children.

In New Jersey, it is the Director of the Division of Consumer Affairs who is empowered to change the schedule of drugs.  I met with Tom Calcagni, former Director of Consumer Affairs, Office of the Attorney General, regarding rescheduling marijuana on 2/15/11, in Newark. He had the power but not the will to reschedule marijuana. I pointed out to him that it was logically inconsistent for the state to say marijuana was a Schedule I drug with no accepted medical uses while at the same time enumerating the medical uses for marijuana.   (See my attached letter to Mr. Calcagni.) Director Calcagni was very interested and promised to have subsequent meetings with me, but after I left his office, all the subsequent meetings were cancelled and he denied my request to reschedule marijuana in New Jersey.

Simply rescheduling marijuana to a different level of controlled substance (Schedules II – V) is not enough. If marijuana is to be legal for any adult to purchase in New Jersey, which Governor Murphy hopes to accomplish as quickly as possible, marijuana should not be considered a controlled dangerous substance at all. Marijuana should be descheduled in New Jersey.

Removing marijuana entirely from the New Jersey Controlled Dangerous Substances Act, N.J.S.A. 24:21-2, is an important measure in legalizing marijuana in the state. 

Even after descheduling, the State can still pass laws against the misuse of marijuana, just like we have laws against the misuse of alcohol, which is not a controlled substance, either. 

Descheduling marijuana in NJ will encourage other states to do likewise, and it will put pressure on the federal government to change its absurd, almost 50-year-old opinion that marijuana is a Schedule I drug, an opinion that is purely political and completely unsupported by science. 

Thank you for your consideration.

Ken Wolski, RN, MPA
Executive Director
Coalition for Medical Marijuana--New Jersey, Inc.



References:

Federal drug law, 21 U.S.C. § 903, gives the states the authority to determine accepted medical use. See, Gonzales v. Oregon, 546 U.S. 243, 269-270 (2006):  
“Congress regulates medical practice insofar as it bars doctors from using their prescription-writing powers as a means to engage in illicit drug dealing and trafficking as conventionally understood. Beyond this, however, the statute manifests no intent to regulate the practice of medicine generally. Federalism… (allows) the States ‘great latitude under their police powers to legislate as to the protection of the lives, limbs, health, comfort, and quiet of all persons.’” Medtronic, Inc. v. Lohr, 518 U.S. 470, 475, 116 S. Ct. 2240, 135 L. Ed. 2d 700 (1996) (quoting Metropolitan Life Ins. Co. v. Massachusetts, 471 U.S. 724, 756, 105 S. Ct. 2380, 85 L. Ed. 2d 728 (1985)).

“Marijuana, Medicine & the Law, Volume I & Volume II,” R.C. Randall, editor, Galen Press, Washington, D.C., 1988.

Congressional Research Service Report for Congress
Medical Marijuana: Review and Analysis of Federal and State Policies, 
Mark Eddy, Specialist in Social Policy, April 2, 2010.

Report of the National Commission on Marihuana and Drug Abuse:
Marijuana: A Signal of Misunderstanding  
(The Shafer Commission Report)
Commissioned by President Richard M. Nixon, March 1972

United States Department of Justice, Drug Enforcement Administration
In The Matter of Marijuana Rescheduling Petition Docket No. 86-22
Opinion and recommended Ruling, Findings of Fact, Conclusions of Law and Decision of
Administrative Law Judge Francis L. Young, September 6, 1988

29 Legal Medical Marijuana States and DC
Laws, Fees, and Possession Limits

Compassionate Investigational New Drug Program

State of New Jersey Department of Health, Medicinal Marijuana Program
New Jersey Compassionate Use Medical Marijuana Act

Emerging Clinical Applications for Cannabis and Cannabinoids:
A Review of the Recent Scientific Literature, Fifth Edition, 4/10/2012
Paul Armentano, Deputy Director, NORML Foundation, Washington, DC

Marijuana and Medicine: Assessing the Science Base (1999)
Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors; Institute of Medicine
Division of Neuroscience and Behavioral Health
National Academy of Sciences, Institute of Medicine

Trends in Pharmacological Sciences
Volume 30, Issue 10, October 2009, Pages 515–527

Physical, Mental, and Moral Effects of Marijuana: The Indian Hemp Drugs Commission Report

National Organization for the Reform of Marijuana Laws (NORML), annual marijuana arrests in the U.S. went from 31,000 in 1966 to 188,000 in 1970:

Professor Lyle Craker, University of Massachusetts/Amherst, unsuccessful 10-year struggle to grow a sufficient supply of marijuana to conduct large scale clinical trials:

Enc.: January 6, 2011 letter to:
Thomas R. Calcagni, Acting Director, Division of Consumer Affairs
P.O. Box 45027, Newark, NJ 07101
Re: Compassionate Use Medical Marijuana Act effectively rescheduled marijuana in New Jersey